These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 19241525

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V, Kosowska K, Bozdogan B, Kelly LM, Smith K, Ednie LM, Lin G, Credito KL, Clark CL, McGhee P, Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Increasing telithromycin resistance among Streptococcus pyogenes in Europe.
    Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H, Doern GV.
    J Antimicrob Chemother; 2008 Mar; 61(3):603-11. PubMed ID: 18218647
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis.
    Grivea IN, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):256-61. PubMed ID: 16377695
    [Abstract] [Full Text] [Related]

  • 32. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D.
    Acta Med Croatica; 2004 Jan; 58(4):301-6. PubMed ID: 15700686
    [Abstract] [Full Text] [Related]

  • 33. [Activity of telithromycin and other oral antibiotics against respiratory tract pathogens with acquired mechanisms of resistance].
    Gómez-Garcés JL, Alós JI, Hernáiz C, Gómez C.
    Enferm Infecc Microbiol Clin; 2004 Jan; 22(6):323-7. PubMed ID: 15228898
    [Abstract] [Full Text] [Related]

  • 34. Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003).
    Schito GC, Felmingham D.
    Int J Antimicrob Agents; 2005 Dec; 26(6):479-85. PubMed ID: 16289710
    [Abstract] [Full Text] [Related]

  • 35. Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.
    Kozlov RS, Bogdanovitch TM, Appelbaum PC, Ednie L, Stratchounski LS, Jacobs MR, Bozdogan B.
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2963-8. PubMed ID: 12183254
    [Abstract] [Full Text] [Related]

  • 36. Effect of telithromycin and azithromycin on nasopharyngeal bacterial flora in patients with acute maxillary sinusitis.
    Brook I, Hausfeld JN.
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):442-5. PubMed ID: 16618915
    [Abstract] [Full Text] [Related]

  • 37. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
    Shortridge VD, Zhong P, Cao Z, Beyer JM, Almer LS, Ramer NC, Doktor SZ, Flamm RK.
    Antimicrob Agents Chemother; 2002 Mar; 46(3):783-6. PubMed ID: 11850262
    [Abstract] [Full Text] [Related]

  • 38. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
    Kays MB, Lisek CR, Denys GA.
    Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118
    [Abstract] [Full Text] [Related]

  • 39. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004).
    Inoue M, Farrell DJ, Kaneko K, Akizawa K, Fujita S, Kaku M, Igari J, Yamaguchi K, Yamanaka K, Murase M, Asari S, Hirakata Y, Baba H, Itaha H.
    Microb Drug Resist; 2008 Jun; 14(2):109-17. PubMed ID: 18500920
    [Abstract] [Full Text] [Related]

  • 40. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
    Hsueh PR, Teng LJ, Lee CM, Huang WK, Wu TL, Wan JH, Yang D, Shyr JM, Chuang YC, Yan JJ, Lu JJ, Wu JJ, Ko WC, Chang FY, Yang YC, Lau YJ, Liu YC, Leu HS, Liu CY, Luh KT, SMART Program 2001 Data.
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.